Analytical Data
-
基因名
GLC8
- Application
-
别名
GLC8;Protein GLC8
-
种属
Saccharomyces cerevisiae
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P41818
-
表达区间
1-229aa
-
氨基酸序列
MGGILKNPLA LSPEQLAQQD PETLEEFRRQ VYENTQKNAK LTSHKRNIPG LDNTKEEGEI IGTSSTFLPK DTLSLKHEQD MLAKMTPEER VQWNQRNLAE NEITKKQFQD IHIDEPKTPY QGAVDPHGEY YRVDDDEDED NSDKKPCQVA NDDIDDLSLG EPEFEIKENK QPDFETNDEN DEDSPEARHK KFEEMRKKHY DVRAIFNKKS REALKDEDED EDDSTTKEP
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GLC8, a gene encoding a protein involved in various cellular processes, has attracted significant research attention due to its role in regulating glucose metabolism and its implications in metabolic disorders. GLC8 functions as a cofactor for protein phosphorylation and plays a crucial part in the signaling pathways that control the cellular response to changing energy demands. Recent studies have highlighted its involvement in insulin signaling and glucose homeostasis, suggesting that dysregulation of GLC8 may contribute to the development of insulin resistance and type 2 diabetes. Additionally, GLC8 has emerged as a potential target for therapeutic interventions aimed at improving metabolic health. As researchers delve deeper into the molecular mechanisms underlying GLC8's functions, the protein's significance in both fundamental biology and clinical applications continues to expand, paving the way for innovative strategies in managing metabolic diseases. Understanding GLC8 at the molecular level could lead to novel biomarkers for early detection and personalized treatment options for patients affected by metabolic dysfunctions.
